Lighthouse Investment Partners’s Avadel Pharmaceuticals AVDL Stock Holding History

Lighthouse Investment Partners’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,692	Closed	-$317K	–	731
2025 Q4	$317K	Buy	+14,692	New	+$285K	0.01%	685

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lighthouse Investment Partners's AVDL Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 14,692 shares — an estimated $317K sold.

Lighthouse Investment Partners first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $317K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Lighthouse Investment Partners reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Lighthouse Investment Partners sold 14,692 Avadel Pharmaceuticals shares in Q1 2026, an estimated $317K.
Lighthouse Investment Partners first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
Lighthouse Investment Partners's Avadel Pharmaceuticals position peaked at $317K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.